Make your company fundable, and walk into the right rooms.
Investor readiness for women's health companies, plus a route into the European investors who actually fund this category and into non-dilutive public funding.
Most femtech rounds don't fail on the deck. They fail because the company is pitching to people who were never going to write the cheque.
What you get out of it
- Genuinely fundable, not just pitch-ready
- In front of investors with a real women's health thesis
- Non-dilutive capital captured alongside private money, not instead of it
- Funding strategy — how much, from where, in what order
- Investor readiness and narrative
- Investor landscape mapping: who funds what, at what stage, in which geography
- Investor roadshows and warm introductions
- Public and non-dilutive funding — EIC Accelerator, ENISA, CDTI, Banco Português de Fomento, EU4Health
- Ecosystem visibility in the run-up to a round
Startups and scale-ups preparing to raise — a seed round, a growth round, or a first non-dilutive grant.
"We make you investable, then we make sure the right people are looking."
Before you ask us
We can guarantee that we will only introduce you when we think you're ready, because our name is on it. Introductions are made from a network we've spent years building, and burning it on a company that isn't ready costs us more than it costs you. If the readiness work says you should wait two quarters, we'll say so.
The realistic list is shorter than the published one. In Spain, ENISA and CDTI are the workhorses for early-stage and R&D-heavy companies respectively. In Portugal, Banco Português de Fomento and ANI. At European level, the EIC Accelerator is the headline instrument and EU4Health consortium calls are worth pursuing if you can find the right partner. Which of these fit depends on your stage, legal structure and whether your work is classifiable as R&D — which is the first thing we check.
A small, identifiable group of dedicated funds, plus a much larger group of generalist health and consumer investors who will look at femtech but need the case framed in their language. Mapping that second group properly is usually where a round is won — the dedicated funds are a short list every founder already has.
The advisory work is a fixed fee. Where we make introductions that lead to a closed round, there is a success component, agreed in writing and kept contractually separate from the advisory engagement so there's no ambiguity about what you're paying for.